Director Shareholding
December 30 2004 - 7:11AM
UK Regulatory
RNS Number:9094G
Cambridge Antibody Tech Group PLC
30 December 2004
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
John Aston
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 Above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Grant of Option under Restricted Element of Executive Incentive Plan
7) Number of shares/amount of
stock acquired
Nil
8) Percentage of issued class
Nil
9) Number of shares/amount
of stock disposed
None
10) Percentage of issued class
None
11) Class of security
Ordinary 10 pence shares
12) Price per share
N/A
13) Date of transaction
30 December 2004
14) Date company informed
30 December 2004
15) Total holding following this notification
43,088
16) Total percentage holding of issued class following this notification
0.083%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
30 December 2004
18) Period during which or date on which exercisable
30 December 2007 to 29 December 2010
19) Total amount paid (if any) for grant of the option
Nil
20) Description of shares or debentures involved: class, number
22,613 Ordinary 10 pence shares
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
10 pence per share subject to Award
22) Total number of shares or debentures over which options held
following this notification
149,074 of which:
86,051 are Options under Company Share Option Plan
56,765 are Restricted Share Awards under Executive Incentive Plan
6,258 are Matching Shares under Executive Incentive Plan
23) Any additional information
Awards granted under the Executive Incentive Plan are subject to a performance
condition
24) Name of contact and telephone number for queries
Justin Hoskins: 01223 898589
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett
Date of Notification 30 December 2004
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEADAEDEXLFFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024